-
Gastrointestinal Cancer: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Dr O'Reilly
Editor-in-Chief: Eileen M. O'Relly
Dr. Eileen M. O’Reilly is an Associate Member of the in the GI Medical Oncology service at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York and an Associate Professor of Medicine at Weill Medical College of Cornell University. Dr. O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland, where she was born. She completed her residency training in Ireland and Fellowship training at MSKCC and has been a faculty member in the GI Oncology service at MSKCC since that time. Dr. O’Reilly has pancreatic, biliary, neuroendocrine and primary liver cancers as the major focus of her research and clinical activities. Specific research initiatives include integration of molecular-based therapies for the treatment of pancreas cancer along with development of adjvuant and neoadjuvant therapy. At a national level, Dr. O’Reilly is a member of CALGB’s GI core committee and also participates in RTOG and ACOSOG and is a member of the Scientific Advisory Board of the Lustgarten Foundation. Dr. O’Reilly teaches and mentors Medical Oncology Fellows and Junior Faculty and has numerous teaching awards. Dr. O’Reilly’s insitutional administrative commitments include membership of MSKCC’s IRB, Research Council, Clinical Council and Medical Board. Dr. O’Reilly is also the current President of the MSKCC medical staff.
-
Call For Submissions
Submit Original Research Article, Review, Case Report, or Rapid Communication in Gastrointestinal Cancer: Targets and Therapy




